124 related articles for article (PubMed ID: 27347751)
21. Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis.
Watkins AJ; Huang Y; Ye H; Chanudet E; Johnson N; Hamoudi R; Liu H; Dong G; Attygalle A; McPhail ED; Law ME; Isaacson PG; de Leval L; Wotherspoon A; Du MQ
J Pathol; 2010 Mar; 220(4):461-74. PubMed ID: 20077527
[TBL] [Abstract][Full Text] [Related]
22. First reported case of splenic diffuse red pulp small B-cell lymphoma with novel mutations in CXCR4 and TRAF3 genes.
Zheng S; Lin L; Jin J; Liu F; Wei J; Feng Y; Zhang Y; Luo H; Qin J; Feng W
Int J Hematol; 2023 Sep; 118(3):394-399. PubMed ID: 36935465
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemistry for BRAF V600E in the Differential Diagnosis of Hairy Cell Leukemia vs Other Splenic B-Cell Lymphomas.
Turakhia S; Lanigan C; Hamadeh F; Swerdlow SH; Tubbs RR; Cook JR
Am J Clin Pathol; 2015 Jul; 144(1):87-93. PubMed ID: 26071465
[TBL] [Abstract][Full Text] [Related]
24. Cyclin A2 as a potential differential marker of splenic diffuse red pulp small B-cell lymphoma: a report of the first case.
Ben Younes K; Doghri R; Mrad K; Ben Romdhane N; Ben Aissa-Fennira F
Ann Hematol; 2017 Mar; 96(3):511-512. PubMed ID: 27761608
[No Abstract] [Full Text] [Related]
25. Splenic marginal zone lymphoma: a distinctive type of low-grade B-cell lymphoma. A clinicopathological study of 13 cases.
Mollejo M; Menárguez J; Lloret E; Sánchez A; Campo E; Algara P; Cristóbal E; Sánchez E; Piris MA
Am J Surg Pathol; 1995 Oct; 19(10):1146-57. PubMed ID: 7573673
[TBL] [Abstract][Full Text] [Related]
26. CD27-positive hairy cell leukemia-Japanese variant.
Tabata R; Tabata C; Iwama H; Yasumizu R; Kojima M
Virchows Arch; 2016 Mar; 468(3):375-9. PubMed ID: 26868143
[TBL] [Abstract][Full Text] [Related]
27. [Clinical features and prognosis of eight patients with splenic diffuse red pulp small B-cell lymphoma].
Zhang XL; Luo J; Zhang JJ; Chen L; Shen Y; Yi HM; Fan LQ; Mi JQ
Zhonghua Xue Ye Xue Za Zhi; 2022 Dec; 43(12):1028-1033. PubMed ID: 36709109
[No Abstract] [Full Text] [Related]
28. Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma.
Kiel MJ; Velusamy T; Betz BL; Zhao L; Weigelin HG; Chiang MY; Huebner-Chan DR; Bailey NG; Yang DT; Bhagat G; Miranda RN; Bahler DW; Medeiros LJ; Lim MS; Elenitoba-Johnson KS
J Exp Med; 2012 Aug; 209(9):1553-65. PubMed ID: 22891276
[TBL] [Abstract][Full Text] [Related]
29. Bone marrow histopathology in the diagnostic evaluation of splenic marginal-zone and splenic diffuse red pulp small B-cell lymphoma: a reliable substitute for spleen histopathology?
Ponzoni M; Kanellis G; Pouliou E; Baliakas P; Scarfò L; Ferreri AJ; Doglioni C; Bikos V; Dagklis A; Anagnostopoulos A; Ghia P; Stamatopoulos K; Papadaki T
Am J Surg Pathol; 2012 Nov; 36(11):1609-18. PubMed ID: 23073320
[TBL] [Abstract][Full Text] [Related]
30. Splenic marginal zone B-cell lymphoma: a distinct clinicopathological and molecular entity. Recent advances in ontogeny and classification.
Traverse-Glehen A; Baseggio L; Salles G; Felman P; Berger F
Curr Opin Oncol; 2011 Sep; 23(5):441-8. PubMed ID: 21760505
[TBL] [Abstract][Full Text] [Related]
31. Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease.
Cao XX; Meng Q; Cai H; He TH; Zhang CL; Su W; Sun J; Li Y; Xu W; Zhou DB; Li J
Ann Hematol; 2017 Jun; 96(6):971-976. PubMed ID: 28280994
[TBL] [Abstract][Full Text] [Related]
32. Splenic marginal zone lymphoma with micronodular T-cell rich B-cell lymphoma.
Wang SA; Olson N; Zukerberg L; Harris NL
Am J Surg Pathol; 2006 Jan; 30(1):128-32. PubMed ID: 16330953
[TBL] [Abstract][Full Text] [Related]
33. [Cytogenetic study of 4 patients diagnosed with splenic B-cell lymphoma with villous circulating cells].
Solé F; Woessner S; Florensa L; Besses C; Palacín A; Martí M; Sans-Sabrafén J
Sangre (Barc); 1993 Aug; 38(4):335-7. PubMed ID: 8235950
[TBL] [Abstract][Full Text] [Related]
34. Splenic marginal zone lymphoma: Clinical clustering of immunoglobulin heavy chain repertoires.
Arcaini L; Zibellini S; Passamonti F; Rattotti S; Lucioni M; Invernizzi R; Merli M; Rizzi S; Boveri E; Rumi E; Astori C; Picone C; Varettoni M; Pascutto C; Paulli M; Lazzarino M
Blood Cells Mol Dis; 2009; 42(3):286-91. PubMed ID: 19250848
[TBL] [Abstract][Full Text] [Related]
35. Toll-like receptor expression and function differ between splenic marginal zone B cell lymphoma and splenic diffuse red pulp B cell lymphoma.
Verney A; Traverse-Glehen A; Callet-Bauchu E; Jallades L; Magaud JP; Salles G; Genestier L; Baseggio L
Oncotarget; 2018 May; 9(34):23589-23598. PubMed ID: 29805758
[TBL] [Abstract][Full Text] [Related]
36. Relevance of a scoring system including CD11c expression in the identification of splenic diffuse red pulp small B-cell lymphoma (SRPL).
Baseggio L; Traverse-Glehen A; Callet-Bauchu E; Morel D; Magaud JP; Berger F; Salles G; Felman P
Hematol Oncol; 2011 Mar; 29(1):47-51. PubMed ID: 20677173
[TBL] [Abstract][Full Text] [Related]
37. Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep Sequencing.
Parry M; Rose-Zerilli MJ; Ljungström V; Gibson J; Wang J; Walewska R; Parker H; Parker A; Davis Z; Gardiner A; McIver-Brown N; Kalpadakis C; Xochelli A; Anagnostopoulos A; Fazi C; de Castro DG; Dearden C; Pratt G; Rosenquist R; Ashton-Key M; Forconi F; Collins A; Ghia P; Matutes E; Pangalis G; Stamatopoulos K; Oscier D; Strefford JC
Clin Cancer Res; 2015 Sep; 21(18):4174-4183. PubMed ID: 25779943
[TBL] [Abstract][Full Text] [Related]
38. Frequent MYD88 L265P and CD79B Mutations in Primary Breast Diffuse Large B-Cell Lymphoma.
Taniguchi K; Takata K; Chuang SS; Miyata-Takata T; Sato Y; Satou A; Hashimoto Y; Tamura M; Nagakita K; Ohnishi N; Noujima-Harada M; Tabata T; Kikuti YY; Maeda Y; Nakamura N; Tanimoto M; Yoshino T
Am J Surg Pathol; 2016 Mar; 40(3):324-34. PubMed ID: 26752547
[TBL] [Abstract][Full Text] [Related]
39. Splenic marginal zone lymphoma with increased number of blasts: an aggressive variant?
Lloret E; Mollejo M; Mateo MS; Villuendas R; Algara P; Martínez P; Piris MA
Hum Pathol; 1999 Oct; 30(10):1153-60. PubMed ID: 10534161
[TBL] [Abstract][Full Text] [Related]
40. Clinical and prognostic significance of aberrant T-cell marker expression in 225 cases of de novo diffuse large B-cell lymphoma and 276 cases of other B-cell lymphomas.
Tsuyama N; Ennishi D; Yokoyama M; Baba S; Asaka R; Mishima Y; Terui Y; Hatake K; Takeuchi K
Oncotarget; 2017 May; 8(20):33487-33500. PubMed ID: 28380441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]